JCCG 活動情報 －論文投稿 2016 年―
（主）
：主論文

神経芽腫委員会
Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, Fukuzawa M, Okuyama H. Can neoadjuvant
chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors
at the time of diagnosis?. Pediatr Surg Int. 32:209. 2016. PMID:26763000
Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, Fukuzawa M, Okuyama H. Can image-definedrisk factors predict surgical complications in localized neuroblastoma?. Eur J Pediatr Surg. 26:117. 2016.
PMID:26528852
Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, Weiss WA. Neuroblasoma.
Nat Rev Dis Primers. 2:16078. 2016. PMID:27830764
田尻達郎. 【小児固形がんの最新トピックス】神経芽腫のトピックス. 小児外科. 48:1185. 2016.

腎腫瘍委員会
Oue T, Koshinaga T, Takimoto T, Okita H, Tanaka Y, Nozaki M, Haruta M, Kaneko Y, Fukuzawa M.
Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive
than that in the National Wilms' Tumor Study 5. Pediatr Surg Int. 32:851. 2016. PMID:27473009

肝腫瘍委員会
檜山英三. 小児がん臨床研究プロトコルの実際「肝腫瘍」, よくわかる臨床研究～小児がん～. 医薬ジャーナル社:154. 2016.
Honda S, Minato M, Suzuki H, Fujiyoshi M, Miyagi H, Haruta M, Kaneko Y, Hatanaka KC, Hiyama E,Kamijo T, Okada T, Taketomi A. Clinical prognostic value of DNA methylation in hepatoblastoma: Fournovel tumor suppressor candidates. Cancer Sci. 107:812. 2016. PMID:26991471
Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, KuriharaS, Ueda Y, Onitake Y. Resectability and tumor response after preoperative chemotherapy inhepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol. JPediatr Surg. 51:2053. 2016. PMID:27712887
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH,Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T,Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P. Riskstratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors
International Collaboration. Lancet Oncol:2016. doi:10.1016/S1470-2045(16)30598-8. [Epub ahead ofprint]

横紋筋肉腫委員会
Hosoi H. Current status of treatment for pediatric rhabdomyosarcoma in the USA and Japan. Pediatr Int.
58:81. 2016. PMID:26646016

リンパ腫委員会
Tsurusawa M, Watanabe T, Gosho M, Mori T, Mitsui T, Sunami S, Kobayashi R, Fukano R, Tanaka F,Fujita N, Inada H, Sekimizu M, Koh K, Kosaka Y, Komada Y, Saito AM, Nakazawa A, Horibe K; lymphoma
committee of the Japanese Pediatric Leukemia/lymphoma Study Group. Randomized study of granulocytecolony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatricleukemia/lymphoma study group B-NHL03 study. Leuk Lymphoma. 57:1657.2016. PMID:26694130（主）Sunami S, Sekimizu M, Takimoto T, Mori T, Mitsui T, Fukano R, Saito AM, Watanabe T, OhshimaK, Fujimoto J, Nakazawa A, Kobayashi R, Horibe K, Tsurusawa M. Prognostic Impact of Intensified
Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the JapanesePediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study. Pediatr Blood Cancer. 63:451. 2016.
PMID:26585702

AML 委員会
Taga T, Watanabe T, Tomizawa D, Kudo K, Terui K, Moritake H, Kinoshita A, Iwamoto S, Nakayama H,Takahashi H, Shimada A, Taki T, Toki T, Ito E, Goto H, Koh K, Saito AM, Horibe K, Nakahata T, Tawa A,Adachi S. Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy forMyeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan. Pediatr Blood Cancer.

63:248. 2016. PMID:26481183
Shiba N, Ohki K, Kobayashi T, Hara Y, Yamato G, Tanoshima R, Ichikawa H, Tomizawa D, Park MJ,Shimada A, Sotomatsu M, Arakawa H, Horibe K, Adachi S, Taga T, Tawa A, Hayashi Y. High PRDM16
expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD,KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma StudyGroup AML-05 trial. Br J Haematol. Br J Haematol. 172:581. 2016. PMID:26684393（主）Takahashi H, Watanabe T, Kinoshita A, Yuza Y, Moritake H, Terui K, Iwamoto S, Nakayama H,Shimada A, Kudo K, Taki T, Yabe M, Matsushita H, Yamashita Y, Koike K, Ogawa A, Kosaka Y, Tomizawa
D, Taga T, Saito AM, Horibe K, Nakahata T, Miyachi H, Tawa A, Adachi S. High event-free survival ratewith minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide
prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group. Br J Haematol. 174:437.
2016. PMID:27029412
Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M,Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S. CXCR4Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report
From the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatr Blood Cancer. 63:1394. 2016.
PMID:27135782
Shiba N, Yoshida K, Shiraishi Y, Okuno Y, Yamato G, Hara Y, Nagata Y, Chiba K, Tanaka H, Terui K, KatoM, Park MJ, Ohki K, Shimada A, Takita J, Tomizawa D, Kudo K, Arakawa H, Adachi S, Taga T, Tawa A,Ito E, Horibe K, Sanada M, Miyano S, Ogawa S, Hayashi Y. Whole-exome sequencing reveals the spectrumof gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia. Br J Haematol.
175:476. 2016. PMID:27470916

CML 委員会
Kurosawa H, Tanizawa A, Tono C, Watanabe A, Shima H, Ito M, Yuza Y, Hotta N, Muramatsu H, Okada
M, Kajiwara R, Moriya Saito A, Mizutani S, Adachi S, Horibe K, Ishii E, Shimada H. Leukostasis in Children
and Adolesecents with Chronic Myeloid Leukemia: Japanse Pediatric Keukemia/Lymphoma Study Group.
Pediatr Blood Cancer. 63:406. 2016. PMID:26485422

HLH/LCH 委員会（主）Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H, Sakashita K, Yasui M, Koga Y, Kobayashi
R, Ishii E, Fujimoto J, Horibe K, Bessho F, Tsunematsu Y, Imashuku S. Intensified and prolonged therapy
comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem
Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 ProtocolStudy. Int J Hematol. 104:99. 2016. PMID:27040279
Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, andmanagement. Pediatr Int. 58:817. 2016. PMID:27289085
森本哲. 組織球症の病態解明と治療の進歩. 日本小児血液・がん学会雑誌. 53:428. 2016.
宮嵜治, 塩田曜子. 造血器疾患の画像診断 2016
32:1135. 2016.

Langerhans cell histiocytosis の画像診断. 臨床画像.